Powell Andrew Kenneth William (CIK 0001304113)

Latest company ownership

Shares held
7,059
Last filed at
Jun 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4
Shares held
4,660
Last filed at
Jun 4, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 1, 2024 Mar 5, 2024 Aclaris Therapeutics, Inc. Director Buy 91.3 +14,500 100.95% $18K
Jan 11, 2019 Jan 14, 2019 LIFECORE BIOMEDICAL, INC. \DE\ Director Buy 90.0 +525 110.53% $6.1K
May 16, 2018 May 17, 2018 Aclaris Therapeutics, Inc. Director Buy 90.0 +500 100.00% $9.6K